Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Hani Al Hashmi"'
Publikováno v:
Hematology Reports, Vol 13, Iss 1 (2021)
For patients with Hodgkin Lymphoma (HL) who experience relapse post allogeneic stem cell transplantation, limited treatment options exist, and the ultimate outcome is poor. Recently, the programmed cell death protein-1 (PD-1) inhibitors have shown re
Externí odkaz:
https://doaj.org/article/2c55f0ed380e4f6599a61dbcd9afff9a
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Cancer cells escape immune recognition by exploiting the programmed cell-death protein 1 (PD-1)/programmed cell-death 1 ligand 1 (PD-L1) immune checkpoint axis. Immune checkpoint inhibitors that target PD-1/PD-L1 unleash the properties of effector T
Externí odkaz:
https://doaj.org/article/8c8109c895994bc88167e58d741cde3a
Autor:
Panayotis Kaloyannidis, Eshrak Al Shaibani, Miral Mashhour, Mohammed Gamil, Ioannis Apostolidis, Hani Al Hashmi, Khalid Ahmed Al Anazi
Publikováno v:
Case Reports in Hematology, Vol 2018 (2018)
The programmed cell death protein-1 (PD-1) inhibitor nivolumab has been recently approved as an effective and safe treatment for patients with refractory/relapsed Hodgkin’s lymphomas. Dermatological adverse events, mainly skin rash, have been repor
Externí odkaz:
https://doaj.org/article/2b10697e24a246e3a994deb54542662f
Autor:
Aeshah A. AlAzmi, Wasil Jastaniah, Hani S. Alhamdan, Arwa O. AlYamani, Waleed I. AlKhudhyr, Shaker M. Abdullah, Mohammed AlZahrani, Ashraf AlSahafi, Tawfiq A. AlOhali, Trad Alkhelawi, Yasser AlObaida, Ayman Allam, Hani Al-Hashmi, Essam Murshid, Fouad AlNajjar, Ashwag AlGethami, Atika AlHarbi, Meteb O. AlFoheidi, Ahmad S. AlSaeed, Hassan Elsolh, Ibraheem Abosoudah, Abdulaziz Ben Obaid, Mohammed AlNahedh
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 476-485 (2020)
PURPOSE Cancer treatment shortages are complex and a persistent problem worldwide. Patients with cancer are most vulnerable to drug shortages, which provides opportunities to examine the extent of the challenge(s) facing Saudi Arabia and to provide r
Externí odkaz:
https://doaj.org/article/4d6bf81edff240d6a38d10d6c4906bb3
Autor:
Hazzaa Al-Zahrani, Aamer Aleem, Fahad Al Mohareb, Said Yousuf Ahmed, Ahmed M Al-Suliman, Hussain H Al Saeed, Mubarak S Al-Ghamdi, Hani Al-Hashmi
Publikováno v:
Journal of Applied Hematology, Vol 10, Iss 3, Pp 77-83 (2019)
Immune thrombocytopenia (ITP) is a disorder characterized by an isolated thrombocytopenia in the absence of an identifiable cause. Management of ITP patients varies according to the clinical presentation, physicians' experience, availability of resou
Externí odkaz:
https://doaj.org/article/7f2e6ca56bd94e2ebf59b5f9b8632fd7
Autor:
Panayotis Kaloyannidis, Mohammed Al Zayer, Mohammed Al Darweesh, Majed Al Batran, Ayed Al Garni, Abdulrahman Al Naim, Hani Al Hashmi, Solaf Kanfar
Publikováno v:
Leukemia & Lymphoma. 64:742-745
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a310fc74737b1981313672a86d585bc7
https://doi.org/10.1080/10428194.2022.2164195
https://doi.org/10.1080/10428194.2022.2164195
Autor:
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Analie Estanislao, Hani Al Hashmi
Publikováno v:
Journal of Blood Medicine.
Panayotis Kaloyannidis, Fatema Abdulla, Enas Mutahar, Haidar Al Hashim, Salman Al Harbi, Analie Estanislao, Hani Al Hashmi Adult Hematology and Stem Cell Transplantation Department, King Fahad Specialist Hospital, Dammam, Saudi ArabiaCorrespondence:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bed36f467cc287ab9eebc87df6a26167
https://www.dovepress.com/risk-assessment-for-newly-diagnosed-fit-young-patients-with-multiple-m-peer-reviewed-fulltext-article-JBM
https://www.dovepress.com/risk-assessment-for-newly-diagnosed-fit-young-patients-with-multiple-m-peer-reviewed-fulltext-article-JBM
Autor:
Ahmed Alaskar, Abdul Kareem Al Momen, Ahmad Al-Saeed, Ahmed Al Sagheir, Amr Hanbali, Ayman Al-Hejazi, Hani Al-Hashmi, Khalid Al-Anazi, Mohsen Al Zahrani, Saud Abu Harbesh, Zayed Al-Zahrani
Publikováno v:
Journal of Applied Hematology, Vol 5, Iss 4, Pp 123-132 (2014)
Myelodysplastic syndromes (MDSs) constitute a heterogeneous group of clonal hematopoietic disorders. A panel of Saudi hematologists representing the Saudi MDS Working Group convened with two international experts to develop the guidelines for MDS dia
Externí odkaz:
https://doaj.org/article/c4ce57f6eefd4e898780666aa311b78e
Autor:
Riad El Fakih, Mohsen Alzahrani, Abdulaziz Hamadah, Khalil Al-Farsi, Tusneem Elhassan, Mohammed F. Essa, Alfadil Haroon, Reem S. Almaghrabi, Khalid Al Anezi, Naif I. AlJohani, Panayotis Kaloyannidis, Ibraheem H. Motabi, Mouhab Ayas, Ashraf M. Suhebeh, Imran K Tailor, Ahmad Alsaeed, Ahmad Alhuraiji, Murtadha Al-Khabori, Moussab Damlaj, Mahmoud Aljurf, Bader Alahmari, Hani Al Hashmi, Syed Osman Ahmed, Sameer Alamoudi, Ibraheem Abosoudah, Feras Alfraih, Saud Alhayli
Publikováno v:
Bone Marrow Transplantation
Background: The coronavirus disease‐2019 (COVID‐19) caused by SARS Coronavirus 2 (SARS‐CoV‐2) is a potentially lethal infection. Cancer patients, and specifically hematopoietic cell transplant (HCT) recipients are severely immunocompromised a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1502f43d0b886ffb622c12323f19d39
https://doi.org/10.1038/s41409-021-01312-y
https://doi.org/10.1038/s41409-021-01312-y
Autor:
Eshrak Al Shaibani, Hani Al Hashmi, Khalid Al Anezi, John Apostolidis, Panayotis Kaloyannidis, Ahmed Buali, Taghreed Hindi, Rawan Omari, Ayed Garni, Eman Eldebawy, Heba Raslan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:e112-e119
Background and purpose: Patients with refractory or relapsed lymphoma diagnosed with bulky disease at relapse or with residual disease post salvage treatment are considered to have dismal outcome, even post autologous hematopoietic stem cell transpla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::029314b9f240c0a12371e7e7db0d4597
https://doi.org/10.1016/j.clml.2020.08.028
https://doi.org/10.1016/j.clml.2020.08.028